Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1990 2
1991 4
1992 2
1993 2
1994 4
1995 4
1996 6
1997 1
1998 2
1999 5
2000 6
2001 10
2002 4
2003 5
2004 10
2005 6
2006 3
2007 7
2008 11
2009 11
2010 17
2011 17
2012 24
2013 17
2014 20
2015 18
2016 13
2017 7
2018 13
2019 16
2020 21
2021 22
2022 22
2023 15
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

333 results

Results by year

Filters applied: . Clear all
Page 1
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Free article. Clinical Trial.
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.
Blood Pressure Lowering Treatment Trialists' Collaboration. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2021 Sep 18;398(10305):1053-1064. doi: 10.1016/S0140-6736(21)01921-8. Epub 2021 Aug 27. Lancet. 2021. PMID: 34461040 Free PMC article.
[Non-inferiority trials].
Angeli F, Verdecchia P, Coiro S, Santucci A, Notaristefano F, Bartolini C, Reboldi G. Angeli F, et al. Among authors: reboldi g. G Ital Cardiol (Rome). 2024 Apr;25(4):262-269. doi: 10.1714/4244.42207. G Ital Cardiol (Rome). 2024. PMID: 38526362 Italian.
SARS-CoV-2 infection and ACE2 inhibition.
Angeli F, Reboldi G, Verdecchia P. Angeli F, et al. Among authors: reboldi g. J Hypertens. 2021 Aug 1;39(8):1555-1558. doi: 10.1097/HJH.0000000000002859. J Hypertens. 2021. PMID: 34188002 No abstract available.
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators; Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, et al. Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757085 Clinical Trial.
SARS-CoV-2 vaccines: Lights and shadows.
Angeli F, Spanevello A, Reboldi G, Visca D, Verdecchia P. Angeli F, et al. Among authors: reboldi g. Eur J Intern Med. 2021 Jun;88:1-8. doi: 10.1016/j.ejim.2021.04.019. Epub 2021 Apr 30. Eur J Intern Med. 2021. PMID: 33966930 Free PMC article. Review.
[Nephrology: where we stand and where we should go].
Quintaliani G, Nordio M, Reboldi G, Aucella F, Brunori G. Quintaliani G, et al. Among authors: reboldi g. G Ital Nefrol. 2021 Jun 24;38(3):2021-vol3. G Ital Nefrol. 2021. PMID: 34169689 Italian.
The SPRINT trial.
Verdecchia P, Angeli F, Reboldi G. Verdecchia P, et al. Among authors: reboldi g. J Am Soc Hypertens. 2015 Oct;9(10):750-753. doi: 10.1016/j.jash.2015.09.001. Epub 2015 Sep 9. J Am Soc Hypertens. 2015. PMID: 26506129 Clinical Trial. No abstract available.
333 results